文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

西班牙不明病因肾衰竭的遗传特征:GENSEN研究

Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.
PubMed 文献 · Am J Kidney Dis · 2024-07-06

GENSEN研究对818例≤45岁、不明病因慢性肾脏病(CKDUE)且eGFR<15mL/min/1.73m2或已透析/移植的患者行529个遗传性肾病基因的高通量测序,24.8%检出致病/可能致病变异,以IV型胶原基因最常见,提示基因检测对CKDUE有诊断价值。

要点

  • ≤45岁CKDUE且晚期肾病患者中,24.8%可经高通量测序检出致病/可能致病变异。
  • IV型胶原基因(COL4A5/COL4A4/COL4A3)占全部基因变异的35%,为最常见。
  • 阳性报告中Alport综合征谱系占35%,遗传性足细胞病占19%。

核心结论

  • 高通量测序可在约四分之一≤45岁CKDUE且晚期肾病患者中检出遗传病因。
  • 遗传学检查可能是评估CKDUE患者的有用工具。

研究设计与样本

  • 病例系列研究,纳入西班牙51个中心的818例≤45岁CKDUE患者。
  • 入组条件为eGFR<15mL/min/1.73m2或接受维持性透析或移植。
  • 采用高通量测序检测529个与遗传性肾病相关的基因。

主要发现

  • 203例(24.8%)检出与遗传模式一致的致病和/或可能致病变异。
  • IV型胶原基因(COL4A5、COL4A4、COL4A3)占全部基因变异的35%。
  • NPHP1、PAX2、UMOD、MUC1、INF2分别占7.3%、5.9%、2.5%、2.5%、2.5%。
  • 共鉴定87个新的致病/可能致病变异。
  • 阳性报告中最常见未诊断疾病为Alport综合征谱系(35%)、遗传性足细胞病(19%)、肾单位肾痨(11%)、常染色体显性肾小管间质肾病(7%)、CAKUT(5%)。

关键数值与推荐

  • 818例中203例(24.8%)检出致病/可能致病变异。
  • 191例(23.3%)报告肾病家族史,203例阳性患者中65例(32.0%)有家族史。

临床怎么用

  • 对≤45岁不明病因且进展至晚期肾病者,可考虑高通量测序辅助病因诊断。
  • 阳性结果有助于明确Alport综合征谱系、遗传性足细胞病等未能临床诊断的疾病。

局限性

  • 存在数据缺失。
  • 自愿入组可能导致选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Chronic kidney disease of unknown etiology (CKDUE) is one of the main global causes of kidney failure. Genetic studies may identify an etiology in these patients, but few studies have implemented genetic testing of CKDUE in a population-based series of patients, which was the focus of the GENSEN Study. STUDY DESIGN: Case series. SETTINGS & PARTICIPANTS: 818 patients aged≤45 years at 51 Spanish centers with CKDUE, and either an estimated glomerular filtration rate of<15mL/min/1.73m2 or treatment with maintenance dialysis or transplantation. OBSERVATIONS: Genetic testing for 529 genes associated with inherited nephropathies using high-throughput sequencing (HTS). Pathogenic and/or likely pathogenic (P/LP) gene variants concordant with the inheritance pattern were detected in 203 patients (24.8%). Variants in type IV collagen genes were the most frequent (COL4A5, COL4A4, COL4A3; 35% of total gene variants), followed by NPHP1, PAX2, UMOD, MUC1, and INF2 (7.3%, 5.9%, 2.5%, 2.5%, and 2.5%, respectively). Overall, 87 novel variants classified as P/LP were identified. The top 5 most common previously undiagnosed diseases were Alport syndrome spectrum (35% of total positive reports), genetic podocytopathies (19%), nephronophthisis (11%), autosomal dominant tubulointerstitial kidney disease (7%), and congenital anomalies of the kidney and urinary tract (CAKUT, 5%). A family history of kidney disease was reported by 191 participants (23.3%) and by 65 of 203 patients (32.0%) with P/LP variants. LIMITATIONS: Missing data, and selection bias resulting from voluntary enrollment. CONCLUSIONS: Genomic testing with HTS identified a genetic cause of kidney disease in approximately one quarter of young patients with CKDUE and advanced kidney disease. These findings suggest that genetic studies are a potentially useful tool for the evaluation of people with CKDUE. PLAIN-LANGUAGE SUMMARY: The cause of kidney disease is unknown for 1 in 5 patients requiring kidney replacement therapy, reflecting possible prior missed treatment opportunities. We assessed the diagnostic utility of genetic testing in children and adults aged≤45 years with either an estimated glomerular filtration rate of<15mL/min/1.73m2 or treatment with maintenance dialysis or transplantation. Genetic testing identified the cause of kidney disease in approximately 1 in 4 patients without a previously known cause of kidney disease, suggesting that genetic studies are a potentially useful tool for the evaluation of these patients.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Blasco M, Quiroga B, García-Aznar JM, et al. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study. Am J Kidney Dis. 2024. PMID: 38972501. doi:10.1053/j.ajkd.2024.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。